Beer S F, Parr J H, Temple R C, Hales C N
University Department of Clinical Biochemistry, Addenbrooke's Hospital, Cambridge, UK.
Clin Endocrinol (Oxf). 1989 Apr;30(4):379-83. doi: 10.1111/j.1365-2265.1989.tb00435.x.
C-peptide and proinsulin levels were studied in hyper and hypothyroidism both pre and post-treatment and in comparison to matched normals. Fasting C-peptide was reduced in untreated hyperthyroidism (0.4 +/- 0.2 (mean +/- SEM) vs 0.7 +/- 0.2 nmol/l, P less than 0.05) but returned to normal levels following treatment. Fasting proinsulin was elevated in untreated hyperthyroidism (3.6 +/- 0.7 vs 2.4 +/- 0.5 pmol/l, P less than 0.05) also returning to normal after treatment. A similar pattern was seen after oral glucose. The increased proinsulin and reduced C-peptide suggest there may be a defect of proinsulin processing in hyperthyroidism. Fasting C-peptide was reduced in untreated hypothyroidism (0.4 +/- 0.1 vs 0.7 +/- 0.1 nmol/l, P less than 0.05) and also returned to normal after treatment. Fasting proinsulin did not differ significantly from controls. However, proinsulin was reduced after oral glucose (4.7 +/- 0.7 vs. 7.9 +/- 2.0 pmol/l, P less than 0.05) as was C-peptide (0.9 +/- 0.2 vs 2.6 +/- 0.3 nmol/l, P less than 0.05). Both returned to normal after treatment. These findings suggest there are abnormalities of proinsulin and C-peptide levels in both hyper and hypothyroidism.
研究了甲状腺功能亢进和减退患者治疗前后的C肽和胰岛素原水平,并与匹配的正常对照进行比较。未经治疗的甲状腺功能亢进患者空腹C肽水平降低(0.4±0.2(均值±标准误)对0.7±0.2 nmol/l,P<0.05),但治疗后恢复正常水平。未经治疗的甲状腺功能亢进患者空腹胰岛素原水平升高(3.6±0.7对2.4±0.5 pmol/l,P<0.05),治疗后也恢复正常。口服葡萄糖后观察到类似模式。胰岛素原增加和C肽减少表明甲状腺功能亢进可能存在胰岛素原加工缺陷。未经治疗的甲状腺功能减退患者空腹C肽水平降低(0.4±0.1对0.7±0.1 nmol/l,P<0.05),治疗后也恢复正常。空腹胰岛素原与对照组无显著差异。然而,口服葡萄糖后胰岛素原降低(4.7±0.7对7.9±2.0 pmol/l,P<0.05),C肽也降低(0.9±0.2对2.6±0.3 nmol/l,P<0.05)。治疗后两者均恢复正常。这些发现表明甲状腺功能亢进和减退患者的胰岛素原和C肽水平均存在异常。